KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInvested CapitalNet Margin

National Health Investors (NHI) Return on Sales (2016 - 2020)

Historic Return on Sales for National Health Investors (NHI) over the last 12 years, with Q2 2020 value amounting to 0.08%.

  • National Health Investors' Return on Sales fell 2500.0% to 0.08% in Q2 2020 from the same period last year, while for Jun 2020 it was 0.08%, marking a year-over-year decrease of 1700.0%. This contributed to the annual value of 0.51% for FY2019, which is 200.0% down from last year.
  • According to the latest figures from Q2 2020, National Health Investors' Return on Sales is 0.08%, which was down 2500.0% from 0.17% recorded in Q1 2020.
  • National Health Investors' 5-year Return on Sales high stood at 0.54% for Q4 2016, and its period low was 0.08% during Q2 2020.
  • In the last 5 years, National Health Investors' Return on Sales had a median value of 0.34% in 2017 and averaged 0.34%.
  • In the last 5 years, National Health Investors' Return on Sales crashed by -2600bps in 2016 and then soared by 800bps in 2017.
  • National Health Investors' Return on Sales (Quarter) stood at 0.54% in 2016, then plummeted by -49bps to 0.28% in 2017, then grew by 0bps to 0.28% in 2018, then decreased by -13bps to 0.24% in 2019, then plummeted by -65bps to 0.08% in 2020.
  • Its Return on Sales was 0.08% in Q2 2020, compared to 0.17% in Q1 2020 and 0.24% in Q4 2019.